Baxter International vs Abbott Laboratories vs Becton Dickinson and 1 More Revenue Comparison
Compare financial metrics side-by-side using real SEC EDGAR data
Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Baxter International 2.96, Abbott Laboratories 12.593, Becton Dickinson 4.983, Boston Scientific 5.442.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Baxter International, Abbott Laboratories, Becton Dickinson, Boston Scientific.| Metric | Baxter International | Abbott Laboratories | Becton Dickinson | Boston Scientific |
|---|---|---|---|---|
| Market Cap | $13.70B | $197.44B | $51.81B | $69.81B |
| Revenue | $2.96B | $12.59B | $4.98B | $5.44B |
| Cost of Revenue | $1.93B | $5.29B | $2.67B | $1.59B |
| Gross Profit | $1.03B | $7.30B | $2.31B | $3.85B |
| Operating Income | $217.00M | $1.78B | $663.00M | $1.18B |
| Net Income | $126.00M | $928.00M | $377.00M | $907.00M |
| R&D Expense | $129.00M | $882.00M | $258.00M | $554.00M |
| Earnings Per Share | $0.24 | $0.53 | $1.37 | $0.61 |
| Gross Margin | 34.9% | 58.0% | 46.5% | 70.7% |
| Operating Margin | 7.3% | 14.2% | 13.3% | 21.6% |
| Net Profit Margin | 4.3% | 7.4% | 7.6% | 16.7% |
| Free Cash Flow | $32.00M | $2.89B | $509.00M | $1.28B |
| Cumulative Free Cash Flow | $35.82B | $142.48B | $39.60B | $27.75B |
| Operating Cash Flow | $285.00M | $2.49B | $652.00M | $1.47B |
| Cash & Equivalents | $2.15B | $5.10B | $708.00M | $539.00M |